Model
Edge
Recursion Pharmaceuticals, Inc.
RXRX
Filing type
144
Filing date
Oct 5, 2026
Updated
Oct 6, 2026 ยท 9:48 AM
Copy reference
Filing
144
Notice of Proposed Sale of Securities